Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00193986
Status:
COMPLETED
Last Update Posted:
2006-11-14
First Post:
2005-09-08
Brief Title:
Assessment of Prepulse Inhibition for Shock Pain Reduction
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Study Overview
Official Title:
Assessment of Prepulse Inhibition for Shock Pain Reduction- Ventricular
Status:
COMPLETED
Status Verified Date:
2006-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patient tolerance of pain from discharges of implantable cardioverter defibrillators ICDs is highly variable It can be influenced by psychological factors physical condition and the number of shocks delivered
It has been shown that cutaneous pain perception can be reduced by delivery of a weak low voltage pulse prepulseprior to the delivery of a stronger shock
A prepulse delivered before a high voltage ICD shock will decrease discomfort compared to a shock of equal energy without a prepulse
It has been shown that cutaneous pain perception can be reduced by delivery of a weak low voltage pulse prepulseprior to the delivery of a stronger shock
A prepulse delivered before a high voltage ICD shock will decrease discomfort compared to a shock of equal energy without a prepulse
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None